Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

ABBV

AbbVie (ABBV)

AbbVie Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NYSE:ABBV
DateTimeSourceHeadlineSymbolCompany
11/08/20196:07AMEdgar (US Regulatory)Current Report Filing (8-k)NYSE:ABBVAbbVie Inc
11/07/20198:41PMPR Newswire (US)AbbVie Announces Results of Early Participation in Exchange Offers and Consent Solicitations for Allergan NotesNYSE:ABBVAbbVie Inc
11/07/20199:18AMEdgar (US Regulatory)Current Report Filing (8-k)NYSE:ABBVAbbVie Inc
11/06/20193:31PMEdgar (US Regulatory)Current Report Filing (8-k)NYSE:ABBVAbbVie Inc
11/06/20193:06PMPR Newswire (US)AbbVie Announces Launch of Private Offering of Senior Unsecured NotesNYSE:ABBVAbbVie Inc
11/06/201910:18AMEdgar (US Regulatory)Quarterly Report (10-q)NYSE:ABBVAbbVie Inc
11/06/20199:58AMDow Jones NewsForm 8.3 - [AbbVie. Inc]NYSE:ABBVAbbVie Inc
11/06/20199:45AMDow Jones NewsForm 8.3 - [Allergan Plc]NYSE:ABBVAbbVie Inc
11/05/201910:10AMDow Jones NewsForm 8.3 - [Allergan Plc]NYSE:ABBVAbbVie Inc
11/04/201910:09AMDow Jones NewsForm 8.3 - [Alletgan Plc]NYSE:ABBVAbbVie Inc
11/04/20198:31AMPR Newswire (US)AbbVie to Showcase Depth of Immunology Portfolio and Pipeline at the 2019 ACR/ARP Annual MeetingNYSE:ABBVAbbVie Inc
11/01/201911:40AMDow Jones NewsForm 8.3 - Allergan PlcNYSE:ABBVAbbVie Inc
11/01/201910:05AMDow Jones NewsAbbVie Narrows Adjusted Profit GuidanceNYSE:ABBVAbbVie Inc
11/01/20198:37AMDow Jones NewsAbbVie 3Q Adjusted Profit, Revenue Beat ExpectationsNYSE:ABBVAbbVie Inc
11/01/20198:27AMDow Jones NewsAbbVie Inc. Raises Quarterly Dividend by 10.3% to $1.18NYSE:ABBVAbbVie Inc
11/01/20197:51AMEdgar (US Regulatory)Current Report Filing (8-k)NYSE:ABBVAbbVie Inc
11/01/20197:47AMPR Newswire (US)AbbVie Reports Third-Quarter 2019 Financial ResultsNYSE:ABBVAbbVie Inc
10/31/201910:43AMDow Jones NewsForm 8.3 - [Allergan Plc]NYSE:ABBVAbbVie Inc
10/31/20199:28AMDow Jones NewsAbbVie: Rinvoq Meets Main Endpoints in Phase 3 Psoriatic Arthritis StudyNYSE:ABBVAbbVie Inc
10/31/20198:45AMPR Newswire (US)RINVOQâ„¢ (upadacitinib) Meets Primary and All Ranked Secondary Endpoints in Phase 3 Study in Psoriatic ArthritisNYSE:ABBVAbbVie Inc
10/30/201910:55AMDow Jones NewsForm 8.3 - Allergan PlcNYSE:ABBVAbbVie Inc
10/29/201911:02AMDow Jones NewsForm 8.3 - [Allergan Plc]NYSE:ABBVAbbVie Inc
10/29/201910:53AMDow Jones NewsForm 8.3 - [AbbVie. Inc]NYSE:ABBVAbbVie Inc
10/29/20199:03AMPR Newswire (US)AbbVie Launches Let Me Be Clear to Empower People with Psoriasis to Speak Up and Seek Freedom from Their DiseaseNYSE:ABBVAbbVie Inc
10/25/201911:13AMDow Jones NewsForm 8.3 - Allergan PlcNYSE:ABBVAbbVie Inc
10/25/201911:10AMDow Jones NewsForm 8.3 - Abbvie IncNYSE:ABBVAbbVie Inc
10/25/20198:26AMEdgar (US Regulatory)Current Report Filing (8-k)NYSE:ABBVAbbVie Inc
10/25/20198:11AMPR Newswire (US)AbbVie Announces Commencement of Exchange Offers and Consent Solicitations for Allergan NotesNYSE:ABBVAbbVie Inc
10/24/20199:04AMDow Jones NewsAbbVie Forms Collaboration with Cystic Fibrosis FoundationNYSE:ABBVAbbVie Inc
10/24/20198:30AMPR Newswire (US)AbbVie to Present at the Wolfe Research Inaugural Healthcare ConferenceNYSE:ABBVAbbVie Inc
 Showing the most relevant articles for your search:NYSE:ABBV